321 related articles for article (PubMed ID: 24313290)
1. Regulation of with-no-lysine kinase signaling by Kelch-like proteins.
Uchida S; Sohara E; Rai T; Sasaki S
Biol Cell; 2014 Feb; 106(2):45-56. PubMed ID: 24313290
[TBL] [Abstract][Full Text] [Related]
2. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
Sohara E; Uchida S
Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
[TBL] [Abstract][Full Text] [Related]
3. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
4. Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases.
Uchida S
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):487-93. PubMed ID: 24992566
[TBL] [Abstract][Full Text] [Related]
5. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
6. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
McCormick JA; Yang CL; Zhang C; Davidge B; Blankenstein KI; Terker AS; Yarbrough B; Meermeier NP; Park HJ; McCully B; West M; Borschewski A; Himmerkus N; Bleich M; Bachmann S; Mutig K; Argaiz ER; Gamba G; Singer JD; Ellison DH
J Clin Invest; 2014 Nov; 124(11):4723-36. PubMed ID: 25250572
[TBL] [Abstract][Full Text] [Related]
7. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
8. Decreased KLHL3 expression is involved in the activation of WNK-OSR1/SPAK-NCC cascade in type 1 diabetic mice.
Guo Q; Zhang Y; Jiang GR; Zhang C
Pflugers Arch; 2021 Feb; 473(2):185-196. PubMed ID: 33432425
[TBL] [Abstract][Full Text] [Related]
9. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP
Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
[TBL] [Abstract][Full Text] [Related]
11. WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.
Brown A; Meor Azlan NF; Wu Z; Zhang J
Acta Pharmacol Sin; 2021 Apr; 42(4):508-517. PubMed ID: 32724175
[TBL] [Abstract][Full Text] [Related]
12. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.
Chiga M; Rafiqi FH; Alessi DR; Sohara E; Ohta A; Rai T; Sasaki S; Uchida S
J Cell Sci; 2011 May; 124(Pt 9):1391-5. PubMed ID: 21486947
[TBL] [Abstract][Full Text] [Related]
13. Generation and analysis of pseudohypoaldosteronism type II knock-in mice caused by a nonsense KLHL3 mutation in the Kelch domain.
Lin CM; Sung CC; Yang SS; Chen YC; Huang SM; Lin SH
FASEB J; 2022 Jun; 36(6):e22363. PubMed ID: 35621709
[TBL] [Abstract][Full Text] [Related]
14. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.
Lin CM; Cheng CJ; Yang SS; Tseng MH; Yen MT; Sung CC; Lin SH
FASEB J; 2019 Jan; 33(1):1051-1061. PubMed ID: 30148674
[TBL] [Abstract][Full Text] [Related]
15. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension.
Wakabayashi M; Mori T; Isobe K; Sohara E; Susa K; Araki Y; Chiga M; Kikuchi E; Nomura N; Mori Y; Matsuo H; Murata T; Nomura S; Asano T; Kawaguchi H; Nonoyama S; Rai T; Sasaki S; Uchida S
Cell Rep; 2013 Mar; 3(3):858-68. PubMed ID: 23453970
[TBL] [Abstract][Full Text] [Related]
16. NCC regulation by WNK signal cascade.
Uchida S; Mori T; Susa K; Sohara E
Front Physiol; 2022; 13():1081261. PubMed ID: 36685207
[TBL] [Abstract][Full Text] [Related]
17. Impaired degradation of WNK by Akt and PKA phosphorylation of KLHL3.
Yoshizaki Y; Mori Y; Tsuzaki Y; Mori T; Nomura N; Wakabayashi M; Takahashi D; Zeniya M; Kikuchi E; Araki Y; Ando F; Isobe K; Nishida H; Ohta A; Susa K; Inoue Y; Chiga M; Rai T; Sasaki S; Uchida S; Sohara E
Biochem Biophys Res Commun; 2015 Nov; 467(2):229-34. PubMed ID: 26435498
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the renal NaCl cotransporter by the WNK/SPAK pathway: lessons learned from genetically altered animals.
Ostrosky-Frid M; Castañeda-Bueno M; Gamba G
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F146-F158. PubMed ID: 30089030
[TBL] [Abstract][Full Text] [Related]
19. Role of KLHL3 and dietary K
Ostrosky-Frid M; Chávez-Canales M; Zhang J; Andrukhova O; Argaiz ER; Lerdo-de-Tejada F; Murillo-de-Ozores A; Sanchez-Navarro A; Rojas-Vega L; Bobadilla NA; Vazquez N; Castañeda-Bueno M; Alessi DR; Gamba G
Am J Physiol Renal Physiol; 2021 May; 320(5):F734-F747. PubMed ID: 33682442
[TBL] [Abstract][Full Text] [Related]
20. Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation.
Schumacher FR; Sorrell FJ; Alessi DR; Bullock AN; Kurz T
Biochem J; 2014 Jun; 460(2):237-46. PubMed ID: 24641320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]